Xin Wu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy (NCT05255861) | Xin Wu | 2022-03-01 |
Track Xin Wu automatically
Every clearance here is in the API, with alerts when new ones post.